Log in or register
Share on LinkedInShare on LinkedIn

ARTICLE · 27 NOVEMBER 2020

German Parliament Passes Bill For Re-ratification Of UPCA

J A Kemp
J A Kemp
Contributor
J A Kemp

J A Kemp

J A Kemp is one of the largest European patent and trade mark attorney firms, with offices in...

View firm profile
Explore more from J A Kemp

On 26 November 2020 the German Parliament (Bundestag) passed the bill required for German ratification of the Unified Patent Court Agreement (UPCA) with 570 votes in favour...

GermanyGovernment, Public Sector
J A Kemp LLP
J A Kemp LLP
Author LinkedIn connections

On 26 November 2020 the German Parliament (Bundestag)  passed the bill required for German ratification of the Unified Patent Court Agreement (UPCA) with 570 votes in favour, easily achieving the two-thirds majority of the 709 Bundestag members  mandated by the Federal Constitutional Court (FCC).

The bill must now be approved by the Federal Council (Budesrat) before signature by the German Government and the Federal President.

There is a possibility of a further complaint to the German Federal Constitutional Court (FCC). If such a complaint is received, the FCC could  again ask the Federal President not to ratify the UPCA and so delay German ratification.

Assuming that Germany is able to complete the ratification process, in order for the Protocol on Provisional Application (PPA) to start (which is necessary to implement the UPCA), two more countries are required to ratify the PPA.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

Register for freeORLog in

View source

Related Articles

Legal Intelligence Newsletters: sign up for the latest legal and regulatory news on your chosen topics

Read more about

See more popular content from

Article

Dissent Channel: Will German Chancellor Friedrich Merz Resign?

Two analysts from Stepwise's Global Strategic Engagement Team debate whether German Chancellor Friedrich Merz can survive the political fallout from the CDU's historic regional election losses in September, or if mounting party pressure will force his resignation. Ian Cameron argues Merz will cling to power despite weakened authority, while Thomas Goldstein contends his chancellorship appears terminal.
GermanyGovernment, Public Sector
Steptoe LLP
Steptoe LLP
Article

Commission Proposes EU Public Procurement Act

The European Commission has proposed replacing the EU's three core procurement directives with a single, directly applicable Regulation that would fundamentally reshape how companies compete for public contracts across Member States. The reform introduces mandatory quality criteria thresholds, embeds ESG considerations as evaluation factors, and establishes new security and European-preference provisions that could restrict participation based on ownership, supply chain exposure, and strategic dependencies.
European UnionGovernment, Public Sector
Jones Day
Jones Day
Article

The AfD’s Victory In Saxony-Anhalt And The Outlook For German Politics, Trade And Economic Policy

Germany's Alternative for Germany (AfD) party achieved a historic victory in Saxony-Anhalt regional elections, winning nearly 44% of the vote and dealing a severe blow to the ruling Christian Democratic Union. The election results are creating political instability that could weaken Berlin's leadership role in the European Union and reshape the bloc's approach to critical trade, industrial policy, and China relations during a pivotal period for European policymaking.
GlobalGovernment, Public Sector
Steptoe LLP
Steptoe LLP
Article

Germany’s Military Modernization Is Shaping The Future Of Europe’s Security And Defense Industry

Germany is positioning itself to become Europe's dominant military power through an extensive defense modernization program that will run through 2039. With defense spending more than doubling since 2020 and investments spanning space, AI, drones, and long-range capabilities, Berlin's military ascendance creates both opportunities and tensions with traditional European defense leaders like France and Poland.
GermanyGovernment, Public Sector
Steptoe LLP
Steptoe LLP
Article

Germany’s New Money Laundering Combating Act

Germany's Federal Ministry of Finance has published a draft bill implementing the EU Anti-Money Laundering Package, introducing sweeping changes to the country's AML framework through a new Money Laundering Combating Act. The legislation expands the scope of obliged entities, modernizes automated account access systems with EU-wide connectivity, and restructures supervisory mechanisms while maintaining direct application of EU regulations for most substantive obligations.
GermanyGovernment, Public Sector
A&O Shearman
A&O Shearman
Article

Leaked Draft German Foreign Direct Investment Screening Act

Germany is modernizing its foreign direct investment screening regime to align with EU standards by 2028. The leaked draft of the new Investment Screening Act reveals a largely familiar framework with elevated statutory protections, but introduces notable changes for EFTA investors and listed company thresholds. Will the final legislation maintain this continuity or introduce more substantial reforms as parliamentary debate unfolds?
GermanyGovernment, Public Sector
A&O Shearman
A&O Shearman
Article

Patents And University Spin-outs: Protecting Academic Innovation

Universities drive innovation across medicine, AI, materials, and clean tech, but academic researchers face a critical challenge: the need to publish conflicts with patent protection requirements for confidentiality. Understanding how to navigate publication deadlines, filing strategies, and IP development can determine whether groundbreaking research becomes a valuable commercial asset or loses protection entirely.
United StatesIntellectual Property
J A Kemp
J A Kemp
Article

UK High Court Upholds Novartis’s Sacubitril Valsartan SPC: What Is The Relevant “product”?

The UK High Court has rejected a challenge to Novartis's supplementary protection certificate for sacubitril and valsartan, addressing a fundamental question about how the "product" protected by an SPC should be defined. The decision clarifies whether a specific co-crystal formulation or the broader combination of active ingredients constitutes the relevant product under the SPC Regulation.
United StatesIntellectual Property
J A Kemp
J A Kemp
Article

UK High Court Upholds Takeda’s Lisdexamfetamine SPC: Will The CJEU Agree?

The UK High Court has ruled on whether lisdexamfetamine (LDX), a pro-drug with no therapeutic activity before conversion to dextroamphetamine, can be considered an "active ingredient" for supplementary protection certificate purposes. This decision addresses a critical question in pharmaceutical patent law that has produced divergent outcomes across European jurisdictions and is currently before the CJEU in multiple pending referrals.
United StatesIntellectual Property
J A Kemp
J A Kemp
Article

Court Of Appeal Update On Timing Of UPC Opt-outs

The Court of Appeal of the Unified Patent Court has confirmed that actions can be brought concerning pending European patent applications approaching grant, and that such actions render subsequently filed opt-outs ineffective. However, a critical question remains unresolved: while the UPC is competent to hear these pre-grant actions, their admissibility based on timing has yet to be determined, leaving patent applicants in uncertain territory regarding opt-out strategy.
United StatesIntellectual Property
J A Kemp
J A Kemp
Video

Navigating Freedom To Operate (FTO): Strategy, Searches And Risk Mitigation (Video)

This webinar explores the critical Freedom to Operate (FTO) process for life sciences companies, examining when FTO assessments are necessary and how to navigate the complex landscape of patent risks. From initial search strategies and cost considerations to evaluating potential infringement risks and implementing ongoing monitoring systems, the session provides practical guidance for managing intellectual property challenges in product development and commercialization.
United StatesIntellectual Property
J A Kemp
J A Kemp